Filing Flows › 8-K events › Tectonic Therapeutic
Tectonic Therapeutic: completion of an acquisition or disposition of assets
Form 8-K filed Nov 5, 2026 · items 2.01
Completion of an acquisition or disposition of assetsTectonic Therapeutic Announces Third Quarter 2026 Financial Results and Recent Business Highlights
What the filing says
Tectonic Therapeutic Announces Third Quarter 2026 Financial Results and Recent Business Highlights • Reported favorable safety, tolerability and pharmacokinetic (“PK”) results from the single ascending-dose portion of the TX2100 Phase 1a clinical trial in healthy adult volunteers; FDA granted TX2100 Fast Track designat
Read the filing on SEC EDGAR →
What usually followsAcross 2,671 8-Ks reporting Item 2.01 (completed acquisition or disposition) in our universe, the stock's median move the next session was +0.1% (typical size ±1.6%, up 52% of the time); over the following 21 sessions, +1.2%. Every item ranked →
What this kind of filing means
Item 2.01 — Completion of an acquisition or disposition of assets. Completing an acquisition or a sale changes the company’s size and mix from this quarter on; the price paid and how it was financed are in the filing.
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.